SS
STIM icon

Steve Schonfeld’s Neuronetics STIM Stock Holding History

Steve Schonfeld’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,751
Closed -$46K – 2989
2026
Q1 		$46K Buy
+31,751
New +$50.3K ﹤0.01% 1982
2025
Q2 		– Sell
-14,209
Closed -$52.3K – 2518
2025
Q1 		$52.3K Buy
+14,209
New +$51.9K ﹤0.01% 2068
2023
Q1 		– Sell
-14,000
Closed -$96.2K – 2624
2022
Q4 		$96.2K Buy
+14,000
New +$66.1K ﹤0.01% 2193

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Steve Schonfeld's STIM Position: Q2 2026 in Review

Steve Schonfeld sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 31,751 shares — an estimated $46K sold.

Steve Schonfeld first reported a position in STIM in Q4 2022 and held it in 3 quarters. The position peaked at $96.2K in Q4 2022. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Steve Schonfeld reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 31,751 Neuronetics shares in Q2 2026, an estimated $46K.
  • Steve Schonfeld first reported a position in Neuronetics in Q4 2022 and held it in 3 quarters.
  • Steve Schonfeld's Neuronetics position peaked at $96.2K in Q4 2022.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.